Central Pacific Bank - Trust Division’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,607
Closed -$341K – 874
2026
Q2
$341K Buy
1,607
+102
+7% +$20K 0.03% 370
2026
Q1
$295K Buy
1,505
+6
+0.4% +$1.17K 0.04% 382
2025
Q4
$260K Buy
+1,499
New +$273K 0.03% 397

Other funds holding DGX

Central Pacific Bank - Trust Division's DGX Position: Q3 2026 in Review

Central Pacific Bank - Trust Division sold out of Quest Diagnostics (DGX) in Q3 2026, closing a stake of 1,607 shares — an estimated $341K sold.

Central Pacific Bank - Trust Division first reported a position in DGX in Q4 2025 and held it in 3 quarters. The position peaked at $341K in Q2 2026. 48 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Central Pacific Bank - Trust Division reported no remaining Quest Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Central Pacific Bank - Trust Division sold 1,607 Quest Diagnostics shares in Q3 2026, an estimated $341K.
  • Central Pacific Bank - Trust Division first reported a position in Quest Diagnostics in Q4 2025 and held it in 3 quarters.
  • Central Pacific Bank - Trust Division's Quest Diagnostics position peaked at $341K in Q2 2026.
  • 48 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.